[HTML][HTML] Assessing drug-induced mitochondrial toxicity in cardiomyocytes: implications for preclinical cardiac safety evaluation
X Tang, Z Wang, S Hu, B Zhou - Pharmaceutics, 2022 - mdpi.com
Drug-induced cardiotoxicity not only leads to the attrition of drugs during development, but
also contributes to the high morbidity and mortality rates of cardiovascular diseases …
also contributes to the high morbidity and mortality rates of cardiovascular diseases …
Assessing Drug-Induced Mitochondrial Toxicity in Cardiomyocytes: Implications for Preclinical Cardiac Safety Evaluation
X Tang, Z Wang, S Hu, B Zhou - Pharmaceutics, 2022 - pubmed.ncbi.nlm.nih.gov
Drug-induced cardiotoxicity not only leads to the attrition of drugs during development, but
also contributes to the high morbidity and mortality rates of cardiovascular diseases …
also contributes to the high morbidity and mortality rates of cardiovascular diseases …
Assessing Drug-Induced Mitochondrial Toxicity in Cardiomyocytes: Implications for Preclinical Cardiac Safety Evaluation.
X Tang, Z Wang, S Hu, B Zhou - Pharmaceutics, 2022 - europepmc.org
Drug-induced cardiotoxicity not only leads to the attrition of drugs during development, but
also contributes to the high morbidity and mortality rates of cardiovascular diseases …
also contributes to the high morbidity and mortality rates of cardiovascular diseases …
[HTML][HTML] Assessing Drug-Induced Mitochondrial Toxicity in Cardiomyocytes: Implications for Preclinical Cardiac Safety Evaluation
X Tang, Z Wang, S Hu, B Zhou - Pharmaceutics, 2022 - ncbi.nlm.nih.gov
Drug-induced cardiotoxicity not only leads to the attrition of drugs during development, but
also contributes to the high morbidity and mortality rates of cardiovascular diseases …
also contributes to the high morbidity and mortality rates of cardiovascular diseases …
Assessing Drug-Induced Mitochondrial Toxicity in Cardiomyocytes: Implications for Preclinical Cardiac Safety Evaluation
X Tang, Z Wang, S Hu, B Zhou - Pharmaceutics, 2022 - search.proquest.com
Drug-induced cardiotoxicity not only leads to the attrition of drugs during development, but
also contributes to the high morbidity and mortality rates of cardiovascular diseases …
also contributes to the high morbidity and mortality rates of cardiovascular diseases …
Assessing Drug-Induced Mitochondrial Toxicity in Cardiomyocytes: Implications for Preclinical Cardiac Safety Evaluation.
X Tang, Z Wang, S Hu, B Zhou - Pharmaceutics, 2022 - search.ebscohost.com
Drug-induced cardiotoxicity not only leads to the attrition of drugs during development, but
also contributes to the high morbidity and mortality rates of cardiovascular diseases …
also contributes to the high morbidity and mortality rates of cardiovascular diseases …
[PDF][PDF] Assessing Drug-Induced Mitochondrial Toxicity in Cardiomyocytes: Implications for Preclinical Cardiac Safety Evaluation. Pharmaceutics 2022, 14, 1313
X Tang, Z Wang, S Hu, B Zhou - 2022 - pdfs.semanticscholar.org
Drug-induced cardiotoxicity not only leads to the attrition of drugs during development, but
also contributes to the high morbidity and mortality rates of cardiovascular diseases …
also contributes to the high morbidity and mortality rates of cardiovascular diseases …
[PDF][PDF] Assessing Drug-Induced Mitochondrial Toxicity in Cardiomyocytes: Implications for Preclinical Cardiac Safety Evaluation. Pharmaceutics 2022, 14, 1313
X Tang, Z Wang, S Hu, B Zhou - 2022 - refp.cohlife.org
Drug-induced cardiotoxicity not only leads to the attrition of drugs during development, but
also contributes to the high morbidity and mortality rates of cardiovascular diseases …
also contributes to the high morbidity and mortality rates of cardiovascular diseases …